arrow
D

David C.S. Huang

University of Melbourne
H指数:101
被引数:4.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The stress-sensing MARCH5 axis governs blood cancer apoptotic resilience via tractable protein–protein interactions

压力感应的MARCH5轴通过可调节的蛋白质-蛋白质相互作用调控血液癌症的凋亡抗性

Blood
IF23.1
2026-09-110
PRE
Re-appraising assays on permeabilized blood cancer cells testing venetoclax or other BH3 mimetic agents selectively targeting pro-survival BCL2 proteins

对渗透的血癌细胞进行再评估试验,测试维奈克拉或选择性靶向促生存BCL2蛋白的其他BH3模拟剂

2025-04-090
OA
NONO interacts with nuclear PKM2 and directs histone H3 phosphorylation to promote triple-negative breast cancer metastasis

NONO与核内PKM2相互作用,并指导组蛋白H3磷酸化以促进三阴性乳腺癌转移

2025-03-100
OA
Differential regulation of BAX and BAK apoptotic activity revealed by small molecules

通过小分子揭示BAX和BAK凋亡活性的差异性调控

2025-03-070
OA
Leveraging synthetic lethality across EP300-mutant solid cancers through selective CBP degradation
2024-06-100
PRE
Identification of selective CBP degraders with robust preclinical PK, PD, efficacy and safety across solid tumor indications
2024-03-220
PRE
Discovery of potent and selective EP300 degraders with anti-cancer activity
2024-03-220
PRE
Discovery of potent and selective EP300 degraders with anti-cancer activity
2023-12-010
PRE
Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer Cells
2023-10-2422
OAAI
Venetoclax treatment in patients with cancer has limited impact on circulating T and NK cells

维尼托克治疗癌症患者对循环T和NK细胞的影响有限

2023-06-1512
OAAI
Pharmacologic Reduction of Mitochondrial Iron Triggers a Noncanonical BAX/BAK Dependent Cell Death
2022-03-0817
OAAI